Bristol Myers Price Prediction and Hype Density Breakdown

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>BMY</div>
BMY -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Bristol Myers Earnings per Diluted Share are fairly stable at the moment as compared to the last year. Bristol Myers reported Earnings per Diluted Share of 2.71 in 2019. Enterprise Value over EBIT is likely to grow to 23.21 in 2020, whereas PPandE Turnover is likely to drop 3.79 in 2020. We analyze noise-free headlines and recent hype associated with Bristol Myers Squibb Company which may create opportunities for some arbitrage if properly timed. Using Bristol Myers hype-based prediction you can estimate the value of Bristol Myers Squibb Company from the prospective of Bristol Myers response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Bristol Myers over a specific investment horizon. Continue to Bristol Myers Basic Forecasting Models to cross-verify your projections.

Bristol Myers After-Hype Price Density Analysis

 Next price density 
  Expected price to next headline 

Bristol Myers Estimiated After-Hype Price Volatility

Current Value
February 20, 2020
After-hype Price
Bristol Myers is very steady asset. Analysis and calculation of next after-hype price of Bristol Myers Squibb is based on 3 months time horizon.

Bristol Myers Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.25  1.17  0.11   0.08  9 Events / Month5 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Bristol Myers Hype Timeline

On the 20th of February Bristol Myers Squibb is traded for 65.08. The entity has historical hype elasticity of 0.11 and average elasticity to hype of competition of -0.08. Bristol Myers Squibb Company is estimated to increase in value after the next headline with price going to jump to 65.83. The average volatility of media hype impact on the company stock price is about 265.91%. The price escalation on the next news is projected to be 0.17% where as daily expected return is currently at 0.25%. The volatility of related hype on Bristol Myers is about 365.63% with expected price after next announcement by competition of 65.0. The company reported last year revenue of 23.86 B. Total Income to common stockholders was 6.2 B with profit before taxes, overhead, and interest of 16.07 B. Considering 30-days investment horizon, the next estimated press release will be in about 9 days.
Continue to Bristol Myers Basic Forecasting Models to cross-verify your projections.

Bristol Myers Related Hype Analysis

At Risk
Allergan Plc(1.00) 11 per month 0.40  0.06  0.96 (0.63)  3.57 
Astrazeneca PLC 0.32 10 per month 0.99 (0.0157)  1.67 (1.38)  5.08 
Bristol Myers Squibb Company 0.44 9 per month 0.99  0.08  2.22 (1.50)  6.54 
GlaxoSmithKline PLC(0.26) 9 per month 0.00 (0.11)  1.43 (1.30)  6.31 
Johnson Johnson 1.09 9 per month 0.12  0.11  1.25 (0.68)  2.78 
Eli Lilly And Company(3.21) 9 per month 0.37  0.25  2.02 (1.31)  5.44 
Merck Company 0.64 7 per month 0.00 (0.13)  1.77 (2.35)  5.09 
Novartis AG(0.17) 10 per month 0.46  0.0488  1.09 (1.11)  3.43 
Pfizer(1.18) 11 per month 0.00 (0.08)  1.67 (1.62)  7.14 
Gilead Sciences 0.13 9 per month 1.01 (0.0023)  2.39 (1.78)  7.33 

Contributor Headline

Latest Prospective on Bristol Myers

Continue to Bristol Myers Basic Forecasting Models to cross-verify your projections. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Company logos by clearbit